Insulin-degludec/insulin-aspart vs insulin-aspart/insulin-protamine-aspart in patients with type 2 diabetes mellitus inadequately controlled with pre- or self-mixed insulin regimens +/- oral antihyperglycaemics

Trial Profile

Insulin-degludec/insulin-aspart vs insulin-aspart/insulin-protamine-aspart in patients with type 2 diabetes mellitus inadequately controlled with pre- or self-mixed insulin regimens +/- oral antihyperglycaemics

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Sep 2013

At a glance

  • Drugs Insulin degludec/insulin aspart (Primary) ; Antihyperglycaemics; Insulin; Insulin aspart/insulin protamine aspart
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
    • 26 Sep 2013 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met.
    • 26 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top